Biocompatible Silicone Parts: What Engineers Should Ask Before Ordering

Biocompatible shows up on a lot of spec sheets. It rarely shows up with the detail a buying committee actually needs to act on it. For a medical device team, that gap matters — a part that's biocompatible in the wrong context, or documented incompletely, can stall a design review or, worse, pass one it shouldn't.

Ordering a biocompatible silicone part isn't a single decision. It's a set of questions that engineering, quality, and regulatory each need answered — about the material, the process that made the part, and where its qualification actually applies. Getting those answers before ordering is faster than discovering the gaps during an audit.

What biocompatible actually needs to specify

A material or process reference to ISO 10993 or USP Class VI is a useful signal — but a signal, not a guarantee that covers your specific application. Both standards cover families of tests tied to contact type and duration, not a blanket certification. Before ordering, ask:

• Which specific tests were performed, and against which standard sections? Cytotoxicity, sensitization, and irritation testing are different from implantation or systemic toxicity testing. Know which your application requires and which the material's documentation actually covers.
• What contact duration and type does the documentation support? Limited contact, prolonged contact, and permanent implant each carry different testing requirements. A material qualified for limited skin contact isn't automatically qualified for prolonged mucosal contact.
• Does the certification apply to the raw material, the finished part, or both? Post-processing, cleaning, and post-curing can introduce residues or byproducts that the raw material certification doesn't account for.

Traceability: what to ask beyond "do you have it"

Traceability is often confirmed as a yes/no question when it should be a process question.

• Can you trace a specific part back to a specific material batch? This matters if a field issue or audit finding requires isolating which parts might be affected.
• What documentation ships with each order or batch? Certificates of Conformance, batch numbers, and relevant test data should be available as standard, not assembled on request after the fact.
• How long are batch records retained, and can they be provided if needed years later? Medical device documentation requirements often outlast a single project timeline.

Cleaning and post-curing: process questions that affect the part, not just the material

A biocompatible raw material doesn't guarantee a biocompatible finished part. What happens after printing affects the outcome:

• What cleaning process is used to remove uncured material, and does it leave residues? This is especially relevant for parts with internal channels or complex geometry where full access for cleaning isn't obvious.
• How is post-curing controlled and verified? Post-curing affects final material properties and the completeness of the cure — inconsistent post-curing can leave a part that doesn't match its qualified material profile.
• Is the process the same for prototype quantities and production quantities? A process that changes between a one-off prototype and a production batch introduces a variable that qualification testing on the prototype won't have accounted for.

Application boundaries: where the material's qualification stops

This is the question buying committees ask least often and need most. A material qualified for one application isn't automatically appropriate for another, even within the same product.

• What contact type and duration was the material actually qualified for, and does your application fall inside or outside that boundary?
• Are there use limitations — temperature range, sterilization method compatibility, chemical exposure — that the qualification doesn't cover?
• Who owns the decision that this application is within the material's qualified use? This should be a documented decision by your quality or regulatory function, not an assumption carried over from the material's general reputation.

Asking these questions before, not after, ordering

None of this replaces your own regulatory pathway or device-specific testing — a material or process signal doesn't substitute for the certification your specific device requires. What it does is put engineering, quality, and a manufacturing partner on the same page before a part enters your program, instead of during an audit or a design review that stalls on documentation gaps.

Spectroplast's true silicone materials are developed specifically for additive manufacturing, with documentation, batch traceability, and Certificates of Conformance available as part of standard production — not assembled after the fact. That's part of what "production-grade" is meant to mean: quality and documentation built into the process, not added on request.

Have questions about material documentation for a specific application? Request material documentation before you place an order.

FAQ: Biocompatible Silicone Parts

Is a biocompatible material certification the same as FDA clearance for my device? No. Material or process compliance with ISO 10993 or USP Class VI indicates the material and process were developed with biocompatibility in mind — it isn't a substitute for the specific regulatory testing and clearance your device requires.

Can the same material be biocompatible for one application but not another? Yes. Biocompatibility qualification is tied to contact type and duration. A material qualified for limited skin contact isn't automatically appropriate for prolonged or implant-level contact.

What documentation should come with a biocompatible silicone part order? At minimum: a Certificate of Conformance, batch traceability, and access to relevant material test data. Ask what's included as standard versus what requires a separate request.

Does 3D printing change the biocompatibility profile of a silicone part compared to molding? The raw material's biocompatibility profile doesn't change with the manufacturing method, but process steps like cleaning and post-curing can affect the finished part. Ask how those steps are controlled and verified for printed parts specifically.

How do I confirm traceability if I need to isolate parts from a specific batch later? Confirm before ordering that individual parts or orders can be traced back to a specific material batch, and that batch records are retained long enough to cover your device's documentation lifecycle.

Who should be involved in evaluating a biocompatible material before ordering? Typically engineering, quality, and regulatory functions together — the application-fit question in particular should be a documented decision, not an assumption based on the material's general reputation.